Giberson Scott 4
4 · SAB Biotherapeutics, Inc. · Filed Jul 17, 2024
Insider Transaction Report
Form 4
Giberson Scott
Director
Transactions
- Award
Stock Option (right to buy)
2024-07-15+20,000→ 20,000 totalExercise: $2.90Exp: 2034-07-15→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest in two equal annual installments on July 15, 2025, and 2026.
- [F2]This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.